The iTrack MIGS procedure is redefining the treatment of early moderate glaucoma.
Performed via an ab-interno approach and using breakthrough microcatheter technology, the iTrack by Nova Eye Medical (www.nova-eye.com) is an atraumatic, tissue-sparing MIGS procedure that achieves excellent clinical outcomes while also preserving the viability of future treatment options.
Based on the same principles of angioplasty, the iTrack combines viscodilation to enlarge Schlemm’s canal and to dilate the distal outflow system, with 360° catheterisation of Schlemm’s canal to remove outflow resistance and improve outflow,1-3 thereby reducing intraocular pressure by an average of 30%.4 It can also reduce the medication burden by an average of 50%.4 There is growing evidence to support the role of iTrack as an adjunct to other MIGS procedures.5
Contact: Nova Eye Medical [email protected]
References
- Stegmann R, Pienaar A, Miller D. Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg. 1999;25(3):316-322.
- Grieshaber MC, Pienaar A, Olivier J, Stegmann R. Clinical evaluation of the aqueous outow system in primary open-angle glaucoma for canaloplasty. Invest Ophthalmol Vis Sci. 2010;51(3):1498-1504.
- Smit BA, Johnstone MA. Effects of viscoelastic injection into Schlemm’s canal in primate and human eyes: potential relevance to viscocanalostomy. Ophthalmology. 2002;109(4):786-792.
- Gallardo MJ, Supnet RA, Ahmed IIK. Viscodilation of Schlemm’s canal for the reduction of IOP via an ab-interno approach. Clinical Ophthalmology. Vol 12. August 2018. https://doi. org/10.2147/OPTH.S177597
- A Retrospective Study of Cataract Surgery with Concomitant Ab-Interno Canaloplasty & Trabecular Bypass Stent in Primary Open Angle Glaucoma Authors: Matthew S. Porter, MD, Mark J. Gallardo, MD, Logan R Vincent, MD, Ahmad Kheirkhah, MD, Arnulfo Garza. ASCRS 2020 Virtual Meeting. ascrs.confex.com/ ascrs/20am/meetingapp.cgi/ Paper/62318
